Frederic Delebecque

Title: The Innovations of Frederic Delebecque

Introduction

Frederic Delebecque is a notable inventor based in Paris, France. He has made significant contributions to the field of vaccine development, particularly through his innovative work with recombinant measles viruses. With a total of 4 patents, his inventions are paving the way for advancements in immunogenic compositions.

Latest Patents

One of his latest patents is titled "Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions." This invention relates to a recombinant measles virus that expresses a heterologous amino acid sequence derived from an antigen of a specific RNA virus. The recombinant measles virus is capable of eliciting a humoral and/or cellular immune response against both the measles virus and the RNA virus. This innovative approach also includes the use of the recombinant measles virus for the preparation of immunogenic compositions.

Career Highlights

Frederic Delebecque has worked with prestigious organizations such as the Centre National de la Recherche Scientifique and Institut Pasteur. His work in these institutions has allowed him to contribute significantly to the scientific community and the advancement of vaccine technology.

Collaborations

Throughout his career, Frederic has collaborated with esteemed colleagues, including Frederic Tangy and Clarisse Lorin. These partnerships have further enhanced his research and development efforts in the field of immunology.

Conclusion

Frederic Delebecque's innovative work in vaccine development and his contributions to the scientific community highlight his importance as an inventor. His patents and collaborations continue to influence the field of immunogenic compositions, showcasing the impact of his research on public health.